We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Angion Biomedica Corporation | NASDAQ:ANGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 0.9437 | 1.09 | 0 | 01:00:00 |
Angion
Biomedica Corp.
51 Charles Lindbergh Boulevard
Uniondale, NY 11553
Phone: 516-326-1200
Fax: 516-307-1659
www.angion.com
October 24, 2014
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Re: | Angion Biomedica Corp. |
Registration Statement on S-1 | |
Filed April 14, 2014 | |
Amendment No. 1 filed May 23, 2014 | |
and Amendment No. 2 filed August 25, 2014 | |
File No. 333-195261 |
Dear Sir or Madam:
Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Act”), Angion Biomedica Corp. (“Angion”) respectfully requests the immediate withdrawal of its Registration Statement on Form S-1 (File No. 333-195261) together with all amendments and exhibits thereto (collectively, the “Registration Statement”), originally filed with the Securities and Exchange Commission (the “Commission”) on April 14, 2014, as amended by Amendment No. 1 filed on May 23, 2014, and Amendment No. 2 filed on August 25, 2014.
Angion requests the withdrawal of the Registration Statement due to current market conditions being unfavorable to proceeding with the offering at this time. The Registration Statement has not been declared effective by the Commission, and Angion confirms that no securities have been or will be sold pursuant to the Registration Statement or the prospectus contained therein. Angion believes that the withdrawal of the Registration Statement is consistent with the public interest and protection of investors, as contemplated by Rule 477.
Angion may undertake a subsequent private offering in reliance on Rule 155(c) under the Act.
October 24, 2014
Page 2
It is our understanding that this request for withdrawal of the Registration Statement will be deemed granted as of the date that it is filed with the Commission unless, within fifteen days after such date, Angion receives a notice from the Commission that this request will not be granted.
Angion acknowledges that no refund will be made for fees paid to the Commission in connection with the filing of the Registration Statement. However, Angion requests, in accordance with Rule 457(p) under the Act, that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to Angion’s account to be offset against the filing fee for the filing of any future registration statement or registration statements.
We appreciate your assistance, and should you have any questions, please feel free to contact me at (516) 326-1200.
Sincerely,
/s/ Michael A. Yamin
Michael A. Yamin, Ph.D.
Vice President
1 Year Angion Biomedica Chart |
1 Month Angion Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions